自動と閉鎖型細胞治療処理システムの市場規模、シェア、動向分析レポート：ワークフロー別、タイプ別、規模別、地域別、およびセグメント動向：2025年～2030年

自動と閉鎖細胞治療処理システム市場の成長と動向

Grand View Research, Inc.の最新レポートによると、自動と閉鎖型細胞治療処理システムの世界市場規模は、2025～2030年にかけて19.8%のCAGRを記録し、2030年には41億2,000万米ドルに達すると予測されています。

市場各社は、細胞治療製品の開発プロセスを加速させるための実行可能な戦略として、自動されたプロセスシステムを導入するために多額の投資を行っており、それによって市場の成長が促進されています。

GMP製造施設の拡大は、商業運営における自動プロセスの導入をさらに後押ししています。さらに、使い捨てチューブセットやバッグの応用範囲が広いことも、治療研究開発の自動を促進しています。さらに、主要企業は、製造ラボにおける自動技術の効果的な導入のための戦略を行っており、有利な収益成長をもたらしています。

COVID-19症例の急増が市場成長に重要な役割を果たすと予測されています。パンデミックにより、自動技術への注目が高まっています。さらに、企業はCOVID-19と闘うための先進的な治療法や再生医療を開発する目的で資金調達を重視しています。産業各社はまた、幹細胞療法、天然キラー細胞療法、エクソソームなどの新しい療法の開発にも注力しています。

自動と閉鎖細胞治療処理システム市場レポートハイライト

• 分離セグメントが市場を独占し、2024年には31.7%のシェアを占め、予測期間には20.7%のCAGRで最速の成長が見込まれます。
• 非幹細胞療法セグメントは2024年に最大の市場収益シェアを占め、予測期間中最も速いCAGRで成長すると予測されます。
• プレコマーシャル/研究開発規模セグメントが2024年に最大の市場収益シェアを占め、予測期間中に最も速いCAGRで成長すると予測されています。
• 北米の自動と閉鎖型細胞治療処理システム市場は、2024年に50.1%の最大シェアを占めました。これは、細胞治療と遺伝子治療の保管、輸送、処理を合理化し、臨床検査と商業化努力の効率を高める統合ソリューションへの需要が増加しているためです。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 自動と閉鎖型細胞治療処理システムの市場変数、動向、範囲

• 市場系統の展望
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• ビジネス環境分析
  • 産業分析-ポーターのファイブフォース分析
  • PESTLE分析

第4章 自動と閉鎖型細胞治療処理システム市場：ワークフロービジネス分析

• ワークフロー市場シェア、2024年と2030年
• ワークフローセグメントダッシュボード
• 市場規模と予測と動向分析、ワークフロー別、2018～2030年
• 分離
• 増殖
• アフェレーシス
• 充填-仕上げ
• 凍結保存
• その他

第5章 自動と閉鎖型細胞治療処理システム市場：タイプビジネス分析

• タイプ別市場シェア、2024年と2030年
• タイプセグメントダッシュボード
• 市場規模と予測と動向分析、タイプ別、2018～2030年
• 幹細胞療法
• 非幹細胞療法

第6章 自動と閉鎖型細胞治療処理システム市場：規模ビジネス分析

• 規模市場シェア、2024年と2030年
• 規模セグメントダッシュボード
• 市場規模と予測と動向分析、規模別、2018～2030年
• プレコマーシャル/研究開発規模
• 商業規模

第7章 自動と閉鎖型細胞治療処理システム市場：ワークフロー、タイプ、規模による国推定・動向分析

• 地域別市場シェア分析、2024年と2030年
• 地域別市場ダッシュボード
• 市場規模と予測動向分析、2018～2030年
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • タイ
  • 韓国
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第8章 競合情勢

• 参加者概要
• 企業の市況分析
• 企業分類
• 戦略マッピング
• 企業プロファイル/上場企業
  • Miltenyi BIoTec
  • Lonza
  • Fresenius Kabi AG
  • Danaher Corporation
  • BioSpherix, LLC
  • Terumo Corporation
  • Sartorius AG
  • ThermoGenesis Holdings, Inc.
  • CELLARES
  • Thermo Fisher Scientific Inc.

List of Tables

• Table 1 List of secondary sources
• Table 2 List of abbreviations
• Table 3 Global automated and closed cell therapy processing systems market, by region, 2018 - 2030 (USD Million)
• Table 4 Global automated and closed cell therapy processing systems market, by workflow, 2018 - 2030 (USD Million)
• Table 5 Global automated and closed cell therapy processing systems market, by type, 2018 - 2030 (USD Million)
• Table 6 Global automated and closed cell therapy processing systems market, by scale, 2018 - 2030 (USD Million)
• Table 7 North America automated and closed cell therapy processing systems market, by country, 2018 - 2030 (USD Million)
• Table 8 North America automated and closed cell therapy processing systems market, by workflow, 2018 - 2030 (USD Million)
• Table 9 North America automated and closed cell therapy processing systems market, by type, 2018 - 2030 (USD Million)
• Table 10 North America automated and closed cell therapy processing systems market, by scale, 2018 - 2030 (USD Million)
• Table 11 U.S. automated and closed cell therapy processing systems market, by workflow, 2018 - 2030 (USD Million)
• Table 12 U.S. Automated and closed cell therapy processing systems market, by type, 2018 - 2030 (USD Million)
• Table 13 U.S. automated and closed cell therapy processing systems market, by scale, 2018 - 2030 (USD Million)
• Table 14 Canada automated and closed cell therapy processing systems market, by workflow, 2018 - 2030 (USD Million)
• Table 15 Canada automated and closed cell therapy processing systems market, by type, 2018 - 2030 (USD Million)
• Table 16 Canada automated and closed cell therapy processing systems market, by scale, 2018 - 2030 (USD Million)
• Table 17 Mexico automated and closed cell therapy processing systems market, by workflow, 2018 - 2030 (USD Million)
• Table 18 Mexico automated and closed cell therapy processing systems market, by type, 2018 - 2030 (USD Million)
• Table 19 Mexico automated and closed cell therapy processing systems market, by scale, 2018 - 2030 (USD Million)
• Table 20 Europe automated and closed cell therapy processing systems market, by country, 2018 - 2030 (USD Million)
• Table 21 Europe automated and closed cell therapy processing systems market, by workflow, 2018 - 2030 (USD Million)
• Table 22 Europe automated and closed cell therapy processing systems market, by type, 2018 - 2030 (USD Million)
• Table 23 Europe automated and closed cell therapy processing systems market, by scale, 2018 - 2030 (USD Million)
• Table 24 UK automated and closed cell therapy processing systems market, by workflow, 2018 - 2030 (USD Million)
• Table 25 UK Automated and closed cell therapy processing systems market, by type, 2018 - 2030 (USD Million)
• Table 26 UK Automated and closed cell therapy processing systems market, by scale, 2018 - 2030 (USD Million)
• Table 27 Germany automated and closed cell therapy processing systems market, by workflow, 2018 - 2030 (USD Million)
• Table 28 Germany automated and closed cell therapy processing systems market, by type, 2018 - 2030 (USD Million)
• Table 29 Germany automated and closed cell therapy processing systems market, by scale, 2018 - 2030 (USD Million)
• Table 30 France automated and closed cell therapy processing systems market, by workflow, 2018 - 2030 (USD Million)
• Table 31 France Automated and closed cell therapy processing systems market, by type, 2018 - 2030 (USD Million)
• Table 32 France Automated and closed cell therapy processing systems market, by scale, 2018 - 2030 (USD Million)
• Table 33 Italy automated and closed cell therapy processing systems market, by workflow, 2018 - 2030 (USD Million)
• Table 34 Italy automated and closed cell therapy processing systems market, by type, 2018 - 2030 (USD Million)
• Table 35 Italy automated and closed cell therapy processing systems market, by scale, 2018 - 2030 (USD Million)
• Table 36 Spain automated and closed cell therapy processing systems market, by workflow, 2018 - 2030 (USD Million)
• Table 37 Spain automated and closed cell therapy processing systems market, by type, 2018 - 2030 (USD Million)
• Table 38 Spain automated and closed cell therapy processing systems market, by scale, 2018 - 2030 (USD Million)
• Table 39 Denmark automated and closed cell therapy processing systems market, by workflow, 2018 - 2030 (USD Million)
• Table 40 Denmark automated and closed cell therapy processing systems market, by type, 2018 - 2030 (USD Million)
• Table 41 Denmark automated and closed cell therapy processing systems market, by scale, 2018 - 2030 (USD Million)
• Table 42 Sweden automated and closed cell therapy processing systems market, by workflow, 2018 - 2030 (USD Million)
• Table 43 Sweden automated and closed cell therapy processing systems market, by type, 2018 - 2030 (USD Million)
• Table 44 Sweden automated and closed cell therapy processing systems market, by scale, 2018 - 2030 (USD Million)
• Table 45 Norway automated and closed cell therapy processing systems market, by workflow, 2018 - 2030 (USD Million)
• Table 46 Norway Automated and closed cell therapy processing systems market, by type, 2018 - 2030 (USD Million)
• Table 47 Norway Automated and closed cell therapy processing systems market, by norway, 2018 - 2030 (USD Million)
• Table 48 Asia Pacific automated and closed cell therapy processing systems market, by country, 2018 - 2030 (USD Million)
• Table 49 Asia Pacific automated and closed cell therapy processing systems market, by workflow, 2018 - 2030 (USD Million)
• Table 50 Asia Pacific automated and closed cell therapy processing systems market, by type, 2018 - 2030 (USD Million)
• Table 51 Asia Pacific automated and closed cell therapy processing systems market, by scale, 2018 - 2030 (USD Million)
• Table 52 Japan automated and closed cell therapy processing systems market, by workflow, 2018 - 2030 (USD Million)
• Table 53 Japan automated and closed cell therapy processing systems market, by type, 2018 - 2030 (USD Million)
• Table 54 Japan automated and closed cell therapy processing systems market, by scale, 2018 - 2030 (USD Million)
• Table 55 China automated and closed cell therapy processing systems market, by workflow, 2018 - 2030 (USD Million)
• Table 56 China automated and closed cell therapy processing systems market, by type, 2018 - 2030 (USD Million)
• Table 57 China automated and closed cell therapy processing systems market, by scale, 2018 - 2030 (USD Million)
• Table 58 India automated and closed cell therapy processing systems market, by workflow, 2018 - 2030 (USD Million)
• Table 59 India automated and closed cell therapy processing systems market, by type, 2018 - 2030 (USD Million)
• Table 60 India automated and closed cell therapy processing systems market, by scale, 2018 - 2030 (USD Million)
• Table 61 Australia automated and closed cell therapy processing systems market, by workflow, 2018 - 2030 (USD Million)
• Table 62 Australia automated and closed cell therapy processing systems market, by type, 2018 - 2030 (USD Million)
• Table 63 Australia automated and closed cell therapy processing systems market, by scale, 2018 - 2030 (USD Million)
• Table 64 South Korea automated and closed cell therapy processing systems market, by workflow, 2018 - 2030 (USD Million)
• Table 65 South Korea automated and closed cell therapy processing systems market, by type, 2018 - 2030 (USD Million)
• Table 66 South Korea automated and closed cell therapy processing systems market, by scale, 2018 - 2030 (USD Million)
• Table 67 Thailand automated and closed cell therapy processing systems market, by workflow, 2018 - 2030 (USD Million)
• Table 68 Thailand automated and closed cell therapy processing systems market, by type, 2018 - 2030 (USD Million)
• Table 69 Thailand automated and closed cell therapy processing systems market, by scale, 2018 - 2030 (USD Million)
• Table 70 Latin America automated and closed cell therapy processing systems market, by country, 2018 - 2030 (USD Million)
• Table 71 Latin America automated and closed cell therapy processing systems market, by workflow, 2018 - 2030 (USD Million)
• Table 72 Latin America automated and closed cell therapy processing systems market, by type, 2018 - 2030 (USD Million)
• Table 73 Latin America automated and closed cell therapy processing systems market, by scale, 2018 - 2030 (USD Million)
• Table 74 Brazil automated and closed cell therapy processing systems market, by workflow, 2018 - 2030 (USD Million)
• Table 75 Brazil automated and closed cell therapy processing systems market, by type, 2018 - 2030 (USD Million)
• Table 76 Brazil automated and closed cell therapy processing systems market, by scale, 2018 - 2030 (USD Million)
• Table 77 Argentina automated and closed cell therapy processing systems market, by workflow, 2018 - 2030 (USD Million)
• Table 78 Argentina automated and closed cell therapy processing systems market, by type, 2018 - 2030 (USD Million)
• Table 79 Argentina automated and closed cell therapy processing systems market, by scale, 2018 - 2030 (USD Million)
• Table 80 Middle East & Africa Automated and closed cell therapy processing systems market, by country, 2018 - 2030 (USD Million)
• Table 81 Middle East & Africa automated and closed cell therapy processing systems market, by workflow, 2018 - 2030 (USD Million)
• Table 82 Middle East & Africa automated and closed cell therapy processing systems market, by type, 2018 - 2030 (USD Million)
• Table 83 Middle East & Africa automated and closed cell therapy processing systems market, by scale, 2018 - 2030 (USD Million)
• Table 84 South Africa automated and closed cell therapy processing systems market, by workflow, 2018 - 2030 (USD Million)
• Table 85 South Africa automated and closed cell therapy processing systems market, by type, 2018 - 2030 (USD Million)
• Table 86 South Africa automated and closed cell therapy processing systems market, by scale, 2018 - 2030 (USD Million)
• Table 87 Saudi Arabia automated and closed cell therapy processing systems market, by workflow, 2018 - 2030 (USD Million)
• Table 88 Saudi Arabia automated and closed cell therapy processing systems market, by type, 2018 - 2030 (USD Million)
• Table 89 Saudi Arabia automated and closed cell therapy processing systems market, by scale, 2018 - 2030 (USD Million)
• Table 90 UAE automated and closed cell therapy processing systems market, by workflow, 2018 - 2030 (USD Million)
• Table 91 UAE automated and closed cell therapy processing systems market, by type, 2018 - 2030 (USD Million)
• Table 92 UAE automated and closed cell therapy processing systems market, by scale, 2018 - 2030 (USD Million)
• Table 93 Kuwait automated and closed cell therapy processing systems market, by workflow, 2018 - 2030 (USD Million)
• Table 94 Kuwait automated and closed cell therapy processing systems market, by type, 2018 - 2030 (USD Million)
• Table 95 Kuwait automated and closed cell therapy processing systems market, by scale, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Automated and closed cell therapy processing systems segmentation
• Fig. 2 Market research process
• Fig. 3 Data triangulation techniques
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value-chain-based sizing & forecasting
• Fig. 7 Market formulation & validation
• Fig. 8 Market snapshot
• Fig. 9 Treatment and end use outlook (USD Million)
• Fig. 10 Competitive landscape
• Fig. 11 Automated and closed cell therapy processing systems market dynamics
• Fig. 12 Automated and closed cell therapy processing systems market market: Porter's five forces analysis
• Fig. 13 Automated and closed cell therapy processing systems market market: PESTLE analysis
• Fig. 14 Automated and closed cell therapy processing systems market market: Workflow segment dashboard
• Fig. 15 Automated and closed cell therapy processing systems market market: Workflow market share analysis, 2024 & 2030
• Fig. 16 Separation market, 2018 - 2030 (USD Million)
• Fig. 17 Expansion market, 2018 - 2030 (USD Million)
• Fig. 18 Apheresis market, 2018 - 2030 (USD Million)
• Fig. 19 Fill- Finish market, 2018 - 2030 (USD Million)
• Fig. 20 Cryopreservation market, 2018 - 2030 (USD Million)
• Fig. 21 Others market, 2018 - 2030 (USD Million)
• Fig. 22 Automated and closed cell therapy processing systems market market: Type segment dashboard
• Fig. 23 Automated and closed cell therapy processing systems market market: Type market share analysis, 2024 & 2030
• Fig. 24 Stem cell therapy market, 2018 - 2030 (USD Million)
• Fig. 25 Non stem cell therapy market, 2018 - 2030 (USD Million)
• Fig. 26 Automated and closed cell therapy processing systems market market: Scale segment dashboard
• Fig. 27 Automated and closed cell therapy processing systems market market: Scale market share analysis, 2024 & 2030
• Fig. 28 Pre-commercial/ R&D scale market, 2018 - 2030 (USD Million)
• Fig. 29 Commercial scale market, 2018 - 2030 (USD Million)
• Fig. 30 Automated and closed cell therapy processing systems market revenue, by region
• Fig. 31 Regional marketplace: Key takeaways
• Fig. 32 Regional marketplace: Key takeaways
• Fig. 33 North America automated and closed cell therapy processing systems market market, 2018 - 2030 (USD Million)
• Fig. 34 U.S. country dynamics
• Fig. 35 U.S. automated and closed cell therapy processing systems market, 2018 - 2030 (USD Million)
• Fig. 36 Canada country dynamics
• Fig. 37 Canada automated and closed cell therapy processing systems market, 2018 - 2030 (USD Million)
• Fig. 38 Mexico country dynamics
• Fig. 39 Mexico automated and closed cell therapy processing systems market, 2018 - 2030 (USD Million)
• Fig. 40 Europe automated and closed cell therapy processing systems market, 2018 - 2030 (USD Million)
• Fig. 41 UK country dynamics
• Fig. 42 UK automated and closed cell therapy processing systems market, 2018 - 2030 (USD Million)
• Fig. 43 Germany country dynamics
• Fig. 44 Germany automated and closed cell therapy processing systems market, 2018 - 2030 (USD Million)
• Fig. 45 France country dynamics
• Fig. 46 France automated and closed cell therapy processing systems market, 2018 - 2030 (USD Million)
• Fig. 47 Italy country dynamics
• Fig. 48 Italy automated and closed cell therapy processing systems market, 2018 - 2030 (USD Million)
• Fig. 49 Spain country dynamics
• Fig. 50 Spain automated and closed cell therapy processing systems market, 2018 - 2030 (USD Million)
• Fig. 51 Denmark country dynamics
• Fig. 52 Denmark automated and closed cell therapy processing systems market, 2018 - 2030 (USD Million)
• Fig. 53 Sweden country dynamics
• Fig. 54 Sweden automated and closed cell therapy processing systems market, 2018 - 2030 (USD Million)
• Fig. 55 Norway country dynamics
• Fig. 56 Norway automated and closed cell therapy processing systems market, 2018 - 2030 (USD Million)
• Fig. 57 Asia Pacific automated and closed cell therapy processing systems market, 2018 - 2030 (USD Million)
• Fig. 58 Japan country dynamics
• Fig. 59 Japan automated and closed cell therapy processing systems market, 2018 - 2030 (USD Million)
• Fig. 60 China country dynamics
• Fig. 61 China automated and closed cell therapy processing systems market, 2018 - 2030 (USD Million)
• Fig. 62 India country dynamics
• Fig. 63 India automated and closed cell therapy processing systems market, 2018 - 2030 (USD Million)
• Fig. 64 Australia country dynamics
• Fig. 65 Australia automated and closed cell therapy processing systems market, 2018 - 2030 (USD Million)
• Fig. 66 Thailand country dynamics
• Fig. 67 Thailand automated and closed cell therapy processing systems market, 2018 - 2030 (USD Million)
• Fig. 68 South Korea country dynamics
• Fig. 69 South Korea automated and closed cell therapy processing systems market, 2018 - 2030 (USD Million)
• Fig. 70 Latin America automated and closed cell therapy processing systems market, 2018 - 2030 (USD Million)
• Fig. 71 Brazil country dynamics
• Fig. 72 Brazil automated and closed cell therapy processing systems market, 2018 - 2030 (USD Million)
• Fig. 73 Argentina country dynamics
• Fig. 74 Argentina automated and closed cell therapy processing systems market, 2018 - 2030 (USD Million)
• Fig. 75 MEA automated and closed cell therapy processing systems market, 2018 - 2030 (USD Million)
• Fig. 76 South Africa country dynamics
• Fig. 77 South Africa automated and closed cell therapy processing systems market, 2018 - 2030 (USD Million)
• Fig. 78 Saudi Arabia country dynamics
• Fig. 79 Saudi Arabia automated and closed cell therapy processing systems market, 2018 - 2030 (USD Million)
• Fig. 80 UAE country dynamics
• Fig. 81 UAE automated and closed cell therapy processing systems market, 2018 - 2030 (USD Million)
• Fig. 82 Kuwait Key country dynamics
• Fig. 83 Kuwait automated and closed cell therapy processing systems market, 2018 - 2030 (USD Million)
• Fig. 84 Company categorization
• Fig. 85 Company market position analysis
• Fig. 86 Strategic framework

Automated And Closed Cell Therapy Processing Systems Market Growth & Trends:

The global automated and closed cell therapy processing systems market size is expected to reach USD 4.12 billion by 2030, registering a CAGR of 19.8% from 2025 to 2030, according to a new report by Grand View Research, Inc. Market players are making significant investments to introduce an automated process system as a viable strategy to accelerate their cell therapy product development process, thereby driving market growth.

The expansion of GMP manufacturing facilities further supports the implementation of automated processes for commercial operations. In addition, the wide application scope of single-use disposable tubing sets and bags also facilitates automated processing of therapy R&D. Moreover, key entities are undertaking strategies for effective implementation of automation technology in manufacturing labs resulting in lucrative revenue growth.

The rapid growth in the cases of COVID-19 is anticipated to play a vital role in the market growth. The pandemic has led to an increased focus on automation technologies. Moreover, the companies emphasized raising funds with an aim to develop advanced therapies and regenerative medicines to fight against COVID-19. Industry players are also concentrating on the development of new therapies, such as stem cell therapy, natural killer cell therapy, exosomes, and others.

Automated And Closed Cell Therapy Processing Systems Market Report Highlights:

• The separation segment dominated the market and accounted for a share of 31.7% in 2024 and is expected to grow at the fastest CAGR of 20.7% over the forecast period.
• The non stem cell therapy segment accounted for the largest market revenue share in 2024 and is expected to grow at the fastest CAGR over the forecast period.
• The pre-commercial/ R&D scale segment accounted for the largest market revenue share in 2024 and is expected to grow at the fastest CAGR over the forecast period.
• North America automated and closed cell therapy processing systems market held the largest share of 50.1% in 2024 owing to the increasing demand for integrated solutions that streamline the storage, transportation, and processing of cell and gene therapies, enhancing the efficiency of clinical trials and commercialization efforts.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Workflow
  • 1.2.2. Type
  • 1.2.3. Scale
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
• 1.8. Model Details
  • 1.8.1. Commodity Flow Analysis
• 1.9. List of Secondary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Automated and Closed Cell Therapy Processing Systems Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Business Environment Analysis
  • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTLE Analysis

Chapter 4. Automated and Closed Cell Therapy Processing Systems Market: Workflow Business Analysis

• 4.1. Workflow Market Share, 2024 & 2030
• 4.2. Workflow Segment Dashboard
• 4.3. Market Size & Forecasts and Trend Analysis, by Workflow, 2018 to 2030 (USD Million)
• 4.4. Separation
  • 4.4.1. Separation market, 2018 - 2030 (USD Million)
• 4.5. Expansion
  • 4.5.1. Expansion market, 2018 - 2030 (USD Million)
• 4.6. Apheresis
  • 4.6.1. Apheresis market, 2018 - 2030 (USD Million)
• 4.7. Fill- Finish
  • 4.7.1. Fill- Finish market, 2018 - 2030 (USD Million)
• 4.8. Cryopreservation
  • 4.8.1. Cryopreservation market, 2018 - 2030 (USD Million)
• 4.9. Others
  • 4.9.1. Others market, 2018 - 2030 (USD Million)

Chapter 5. Automated and Closed Cell Therapy Processing Systems Market: Type Business Analysis

• 5.1. Type Market Share, 2024 & 2030
• 5.2. Type Segment Dashboard
• 5.3. Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
• 5.4. Stem Cell Therapy
  • 5.4.1. Stem cell therapy market, 2018 - 2030 (USD Million)
• 5.5. Non Stem Cell Therapy
  • 5.5.1. Non stem cell therapy market, 2018 - 2030 (USD Million)

Chapter 6. Automated and Closed Cell Therapy Processing Systems Market: Scale Business Analysis

• 6.1. Scale Market Share, 2024 & 2030
• 6.2. Scale Segment Dashboard
• 6.3. Market Size & Forecasts and Trend Analysis, by Scale, 2018 to 2030 (USD Million)
• 6.4. Pre-Commercial/ R&D Scale
  • 6.4.1. Pre-commercial/ R&D scale market, 2018 - 2030 (USD Million)
• 6.5. Commercial Scale
  • 6.5.1. Commercial scale market, 2018 - 2030 (USD Million)

Chapter 7. Automated and Closed Cell Therapy Processing Systems Market: Country Estimates & Trend Analysis by Workflow, Type and Scale

• 7.1. Regional Market Share Analysis, 2024 & 2030
• 7.2. Regional Market Dashboard
• 7.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
• 7.4. North America
  • 7.4.1. North America automated and closed cell therapy processing systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.4.2. U.S.
    • 7.4.2.1. Key country dynamic
    • 7.4.2.2. Regulatory framework
    • 7.4.2.3. Competitive insights
    • 7.4.2.4. U.S. automated and closed cell therapy processing systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.4.3. Canada
    • 7.4.3.1. Key country dynamic
    • 7.4.3.2. Regulatory framework
    • 7.4.3.3. Competitive insights
    • 7.4.3.4. Canada automated and closed cell therapy processing systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.4.4. Mexico
    • 7.4.4.1. Key country dynamic
    • 7.4.4.2. Regulatory framework
    • 7.4.4.3. Competitive insights
    • 7.4.4.4. Mexico automated and closed cell therapy processing systems market estimates and forecasts, 2018 - 2030 (USD Million)
• 7.5. Europe
  • 7.5.1. Europe automated and closed cell therapy processing systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5.2. UK
    • 7.5.2.1. Key country dynamic
    • 7.5.2.2. Regulatory framework
    • 7.5.2.3. Competitive insights
    • 7.5.2.4. UK automated and closed cell therapy processing systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5.3. Germany
    • 7.5.3.1. Key country dynamic
    • 7.5.3.2. Regulatory framework
    • 7.5.3.3. Competitive insights
    • 7.5.3.4. Germany automated and closed cell therapy processing systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5.4. France
    • 7.5.4.1. Key country dynamic
    • 7.5.4.2. Regulatory framework
    • 7.5.4.3. Competitive insights
    • 7.5.4.4. France automated and closed cell therapy processing systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5.5. Italy
    • 7.5.5.1. Key country dynamic
    • 7.5.5.2. Regulatory framework
    • 7.5.5.3. Competitive insights
    • 7.5.5.4. Italy automated and closed cell therapy processing systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5.6. Spain
    • 7.5.6.1. Key country dynamic
    • 7.5.6.2. Regulatory framework
    • 7.5.6.3. Competitive insights
    • 7.5.6.4. Spain automated and closed cell therapy processing systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5.7. Denmark
    • 7.5.7.1. Key country dynamic
    • 7.5.7.2. Regulatory framework
    • 7.5.7.3. Competitive insights
    • 7.5.7.4. Denmark automated and closed cell therapy processing systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5.8. Sweden
    • 7.5.8.1. Key country dynamic
    • 7.5.8.2. Regulatory framework
    • 7.5.8.3. Competitive insights
    • 7.5.8.4. Sweden automated and closed cell therapy processing systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5.9. Norway
    • 7.5.9.1. Key country dynamic
    • 7.5.9.2. Regulatory framework
    • 7.5.9.3. Competitive insights
    • 7.5.9.4. Norway automated and closed cell therapy processing systems market estimates and forecasts, 2018 - 2030 (USD Million)
• 7.6. Asia Pacific
  • 7.6.1. Asia Pacific automated and closed cell therapy processing systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.6.2. Japan
    • 7.6.2.1. Key country dynamic
    • 7.6.2.2. Regulatory framework
    • 7.6.2.3. Competitive insights
    • 7.6.2.4. Japan automated and closed cell therapy processing systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.6.3. China
    • 7.6.3.1. Key country dynamic
    • 7.6.3.2. Regulatory framework
    • 7.6.3.3. Competitive insights
    • 7.6.3.4. China automated and closed cell therapy processing systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.6.4. India
    • 7.6.4.1. Key country dynamic
    • 7.6.4.2. Regulatory framework
    • 7.6.4.3. Competitive insights
    • 7.6.4.4. India automated and closed cell therapy processing systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.6.5. Australia
    • 7.6.5.1. Key country dynamic
    • 7.6.5.2. Regulatory framework
    • 7.6.5.3. Competitive insights
    • 7.6.5.4. Australia automated and closed cell therapy processing systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.6.6. Thailand
    • 7.6.6.1. Key country dynamic
    • 7.6.6.2. Regulatory framework
    • 7.6.6.3. Competitive insights
    • 7.6.6.4. Thailand automated and closed cell therapy processing systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.6.7. South Korea
    • 7.6.7.1. Key country dynamic
    • 7.6.7.2. Regulatory framework
    • 7.6.7.3. Competitive insights
    • 7.6.7.4. South Korea automated and closed cell therapy processing systems market estimates and forecasts, 2018 - 2030 (USD Million)
• 7.7. Latin America
  • 7.7.1. Latin America automated and closed cell therapy processing systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.7.2. Brazil
    • 7.7.2.1. Key country dynamic
    • 7.7.2.2. Regulatory framework
    • 7.7.2.3. Competitive insights
    • 7.7.2.4. Brazil automated and closed cell therapy processing systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.7.3. Argentina
    • 7.7.3.1. Key country dynamic
    • 7.7.3.2. Regulatory framework
    • 7.7.3.3. Competitive insights
    • 7.7.3.4. Argentina automated and closed cell therapy processing systems market estimates and forecasts, 2018 - 2030 (USD Million)
• 7.8. MEA
  • 7.8.1. MEA automated and closed cell therapy processing systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.8.2. South Africa
    • 7.8.2.1. Key country dynamic
    • 7.8.2.2. Regulatory framework
    • 7.8.2.3. Competitive insights
    • 7.8.2.4. South Africa automated and closed cell therapy processing systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.8.3. Saudi Arabia
    • 7.8.3.1. Key country dynamic
    • 7.8.3.2. Regulatory framework
    • 7.8.3.3. Competitive insights
    • 7.8.3.4. Saudi Arabia automated and closed cell therapy processing systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.8.4. UAE
    • 7.8.4.1. Key country dynamic
    • 7.8.4.2. Regulatory framework
    • 7.8.4.3. Competitive insights
    • 7.8.4.4. UAE automated and closed cell therapy processing systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.8.5. Kuwait
    • 7.8.5.1. Key country dynamic
    • 7.8.5.2. Regulatory framework
    • 7.8.5.3. Competitive insights
    • 7.8.5.4. Kuwait automated and closed cell therapy processing systems market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Participant Overview
• 8.2. Company Market Position Analysis
• 8.3. Company Categorization
• 8.4. Strategy Mapping
• 8.5. Company Profiles/Listing
  • 8.5.1. Miltenyi Biotec
    • 8.5.1.1. Overview
    • 8.5.1.2. Financial performance
    • 8.5.1.3. Product benchmarking
    • 8.5.1.4. Strategic initiatives
  • 8.5.2. Lonza
    • 8.5.2.1. Overview
    • 8.5.2.2. Financial performance
    • 8.5.2.3. Product benchmarking
    • 8.5.2.4. Strategic initiatives
  • 8.5.3. Fresenius Kabi AG
    • 8.5.3.1. Overview
    • 8.5.3.2. Financial performance
    • 8.5.3.3. Product benchmarking
    • 8.5.3.4. Strategic initiatives
  • 8.5.4. Danaher Corporation
    • 8.5.4.1. Overview
    • 8.5.4.2. Financial performance
    • 8.5.4.3. Product benchmarking
    • 8.5.4.4. Strategic initiatives
  • 8.5.5. BioSpherix, LLC
    • 8.5.5.1. Overview
    • 8.5.5.2. Financial performance
    • 8.5.5.3. Product benchmarking
    • 8.5.5.4. Strategic initiatives
  • 8.5.6. Terumo Corporation
    • 8.5.6.1. Overview
    • 8.5.6.2. Financial performance
    • 8.5.6.3. Product benchmarking
    • 8.5.6.4. Strategic initiatives
  • 8.5.7. Sartorius AG
    • 8.5.7.1. Overview
    • 8.5.7.2. Financial performance
    • 8.5.7.3. Product benchmarking
    • 8.5.7.4. Strategic initiatives
  • 8.5.8. ThermoGenesis Holdings, Inc.
    • 8.5.8.1. Overview
    • 8.5.8.2. Financial performance
    • 8.5.8.3. Product benchmarking
    • 8.5.8.4. Strategic initiatives
  • 8.5.9. CELLARES
    • 8.5.9.1. Overview
    • 8.5.9.2. Financial performance
    • 8.5.9.3. Product benchmarking
    • 8.5.9.4. Strategic initiatives
  • 8.5.10. Thermo Fisher Scientific Inc.
    • 8.5.10.1. Overview
    • 8.5.10.2. Financial performance
    • 8.5.10.3. Product benchmarking
    • 8.5.10.4. Strategic initiatives